Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 63.50
-0.39 (-0.61%)
Aug 15, 2025, 4:35 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 23.98 million as of August 15, 2025. Its market cap has decreased by -30.60% in one year.
Market Cap
23.98M
Enterprise Value
20.95M
Revenue
5.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
63.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 23.98M, a decrease of -64.21%. That is a compound annual growth rate of -21.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 23.98M | -13.61% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.82B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 4.01B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.02B |